Pharma Nord has launched a new campaign to raise awareness of the importance of coenzyme Q10.
The summer initiative, called ‘When your heart matters’, will run nationwide, with Pharma Nord’s Managing Director as its face; at the age of 77, Bent Henriksen OBE recently climbed Kilimanjaro and says the key to a long and healthy life is Bio-Quinone Active Q10.
The campaign will highlight new research involving Pharma Nord’s Bio-Quinone Active Q10. The two-year Q-SYMBIO study, published in the Journal of the American College of Cardiology, HEART FAILURE, showed the important role it could play as an adjuvant to conventional heart failure therapy.
“Pharma Nord was the first company to bring coenzyme Q10 supplements to Europe and they continue to be our best-selling product. The Q-SYMBIO results are remarkable and we strongly believe that Pharma Nord’s Q10 will play an important role in the future treatment of heart conditions,” Henriksen said.
“There are an estimated seven million people living with cardiovascular disease in the UK. We urge retailers to get involved in our new campaign. We have a range of point of sale materials to help you to communicate the benefits of coenzyme Q10 to your customers.”